Loading…

Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians

The tuberculosis (TB) mortality rate of registered TB patients in Malawi is 23%, and 59% of the deaths occur in the first 2 months of treatment. HIV-related complications appear to be an important cause. Starting antiretroviral therapy early during tuberculosis treatment may improve outcome but prob...

Full description

Saved in:
Bibliographic Details
Published in:Antiviral therapy 2007-01, Vol.12 (4), p.515-521
Main Authors: VAN OOSTERHOUT, Joep J. G, KUMWENDA, Johnstone J, BEADSWORTH, Michael, MATEYU, Gabriel, LONGWE, Temba, BURGER, David M, ZIJLSTRA, Eduard E
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The tuberculosis (TB) mortality rate of registered TB patients in Malawi is 23%, and 59% of the deaths occur in the first 2 months of treatment. HIV-related complications appear to be an important cause. Starting antiretroviral therapy early during tuberculosis treatment may improve outcome but problems often arise with drug interactions, adherence, toxicity and immune reconstitution disease (IRD). We prospectively followed 27 HIV-infected adult Malawians after starting Triomune (a generic fixed drug combination of stavudine, lamivudine and nevirapine) in the second week of tuberculosis treatment. At baseline, 88% had CD4+ T-cell counts
ISSN:1359-6535
2040-2058
DOI:10.1177/135965350701200406